ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,935Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 224

$634K Total Retail Price of All Prescriptions

Rank: 6 out of 224

401 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Vermont
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 401 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

5% of this provider’s 401 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 10,297 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Vermont
WARFARIN SODIUM 481 477 1 10
LEVOTHYROXINE SODIUM 435 413 2 4
FUROSEMIDE 330 311 3 5
CITALOPRAM HBR 299 295 4 15
SIMVASTATIN 274 261 5 1
METOPROLOL TARTRATE 272 258 6 7
LISINOPRIL 253 229 7 2
OMEPRAZOLE 221 211 8 3
AMLODIPINE BESYLATE 190 187 9 8
TRAZODONE HCL 174 173 10 20
METOPROLOL SUCCINATE 167 167 11 11
TRAMADOL HCL 157 151 12 18
ATORVASTATIN CALCIUM 152 149 13 16
GABAPENTIN 148 128 14 14
PREDNISONE 138 137 15 28
PANTOPRAZOLE SODIUM 118 118 16 27
KLOR-CON M20 114 112 17 81
LANTUS 110 106 18 43
POLYETHYLENE GLYCOL 3350 107 91 19 48
ADVAIR DISKUS 105 89 20 23
HYDROCHLOROTHIAZIDE 99 96 21 6
METFORMIN HCL 99 86 21 9
DIGOXIN 99 96 21 58
SULFAMETHOXAZOLE-TRIMETHOPRIM 97 93 24 107
CIPROFLOXACIN HCL 94 86 25 95
DONEPEZIL HCL 94 94 25 36
CARVEDILOL 91 89 27 68
TAMSULOSIN HCL 90 90 28 30
CEPHALEXIN 90 89 28 97
POTASSIUM CHLORIDE 87 86 30 24
BUDESONIDE 85 85 31 117
SERTRALINE HCL 82 77 32 17
ESCITALOPRAM OXALATE 81 79 33 64
CLOPIDOGREL 78 78 34 70
LOSARTAN POTASSIUM 75 75 35 19
FAMOTIDINE 73 69 36 77
RISPERIDONE 69 69 37 50
NOVOLOG 68 64 38 147
PHENYTOIN SODIUM EXTENDED 67 45 39 149
CARBIDOPA-LEVODOPA 67 61 39 80
NYSTATIN 65 65 41 152
TORSEMIDE 62 61 42 113
NYSTOP 62 60 42 100
NEXIUM 62 51 42 34
QUETIAPINE FUMARATE 62 62 42 55
ALLOPURINOL 61 60 46 40
DIOVAN 55 55 47 73
JANUVIA 53 53 48 75
VENLAFAXINE HCL ER 52 47 49 66
RANITIDINE HCL 51 39 50 29
LEVOFLOXACIN 51 51 50 89
GENERLAC 51 47 50 174
IPRATROPIUM-ALBUTEROL 50 50 53 105
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 24, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.